HOME >> BIOLOGY >> NEWS
Powerful ally in life sciences: UH research head to give keynote

HOUSTON, Feb. 6, 2007 Calling the University of Houston 'a powerful ally to the life science industry in our region,' BioHouston is featuring UH's new head of research, Donald L. Birx, as keynote speaker at its next breakfast forum Wednesday, Feb. 14.

BioHouston, a 501(c)(3) founded by regional academic and research institutions, is establishing the Houston region as a global competitor in life science and biotechnology commercialization and technology transfer to generate economic wealth for the area.

With nearly $75 million in annual research expenditures, researchers at UH collaborate with other Texas Medical Center institutions and regional biotechnology companies. Birx, vice chancellor for the UH System and vice president for research for UH, advocates collaborative strategic activities and research clusters that relate to and translate UH's research capabilities, as well as build on the strengths of the university and its community partners.

In his BioHouston talk 'Research Clusters and Industry Partnerships' Birx will outline the cutting-edge plans he has brought to Houston and the research under way at UH. In his address, he plans to cover how his 'clusters' approach translates to interdisciplinary research, UH's push for Tier I status, how his background in applied research and making marketable applications speaks to the areas of tech transfer and IP, and how his finance background enhances his role in managing scientific research endeavors. He also will elaborate on some of the particular cross-disciplinary research areas he sees as being especially dynamic at UH.

Birx holds a Ph.D. in electrical engineering from the University of Dayton, an M.B.A. in finance and M.S. in biophysics from Miami University in Ohio, and a B.S. in engineering physics from the University of California, Berkeley.

Prior to joining UH in 2006, Birx spent a decade at New Mexico State University (NMSU) in Las Cruce
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
6-Feb-2007


Page: 1 2

Related biology news :

1. Quantum biology -- Powerful computer models reveal key biological mechanism
2. Powerful genome ID method extended to humans
3. Powerful technique for multiplying adult stem cells may aid therapies
4. Powerful X-ray beams at Argonne, new electronic flight simulator
5. Powerful toolkit developed for functional profiling of yeast genes
6. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
7. Saudi Arabias KAUST names WHOI first research partner
8. Multinational research: protecting ecology means understanding people, too
9. Newly created cancer stem cells could aid breast cancer research
10. Carnegie Mellons Peter Adams receives EPA research grant
11. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... the launch of the Supplyframe Design Lab . Located in Pasadena, Calif., ... the future of how hardware projects are designed, built and brought to market. ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... Windsor, Connecticut (PRWEB) , ... June 23, 2016 ... ... will introduce a new line of intelligent tools designed, tuned and optimized exclusively ... place September 12–17 in Chicago. The result of a collaboration among several companies ...
Breaking Biology Technology:
Cached News: